Guardant Health, Inc.
GH
$129.69
-$3.53-2.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -433.19M | -416.28M | -398.79M | -413.82M | -416.55M |
| Total Depreciation and Amortization | 38.94M | 39.74M | 40.14M | 41.33M | 41.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 220.92M | 206.21M | 185.30M | 192.55M | 194.44M |
| Change in Net Operating Assets | -14.36M | -14.43M | -49.55M | -58.61M | -92.07M |
| Cash from Operations | -187.69M | -184.76M | -222.90M | -238.55M | -272.26M |
| Capital Expenditure | -49.43M | -48.31M | -39.33M | -33.18M | -32.61M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -58.99M | -58.99M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.23M | -519.91M | 327.73M | 41.10M | 46.10M |
| Cash from Investing | -230.65M | -627.20M | 288.40M | 7.92M | 13.49M |
| Total Debt Issued | 397.47M | 397.47M | 0.00 | -5.03M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 380.69M | 377.81M | 18.76M | 15.05M | 15.39M |
| Repurchase of Common Stock | -35.69M | -75.55M | -78.22M | -78.83M | -74.64M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -26.07M | -28.60M | -4.37M | -2.25M | -7.52M |
| Cash from Financing | 716.41M | 671.13M | -63.83M | -71.05M | -66.77M |
| Foreign Exchange rate Adjustments | -476.00K | 491.00K | -518.00K | 1.92M | 141.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 297.59M | -140.34M | 1.15M | -299.76M | -325.40M |